Treatment Registry
TR-0979 ActiveRecorded October 2026

Compounded tirzepatide

Sold by IRON RX · Oral tablet · every compounded tirzepatide record

Price

TermPublished rateCharged today
Starting monthly rate; plan payment unconfirmed

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$249”

$249Published figureCharged todayNot verified
Price sources
Visit IRON RX

We earn nothing from this link. It opens IRON RX's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • October 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberBoth
CancellationRecurring billing and cancellation deadlines depend on checkout terms. Refunds are considered before clinical review or processing, but may be limited or unavailable after approval, prescribing or pharmacy submission. If treatment is not approved, a refund or alternative may depend on services already performed and applicable fees; the terms do not promise an unconditional full refund.
MembershipNot disclosed
Consult feeNot disclosed

Recorded from ironmedrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — IRON Rx identifies this as a compounded medication. It shows a starting monthly price alongside monthly, three-month and six-month plan options, without tying the headline to an exact invoice. Confirm the prescribed formulation, payment total and renewal terms before enrollment. The service may require a brief video visit depending on the state. State-required video adds no charge, but confirm whether a base consultation fee applies.

3 further notes concern other IRON RX programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0979
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). IRON RX — compounded tirzepatide (TR-0979). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0979

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.